Skip to main content

Table 2 Tumor characteristics of 113 patients treated with TPFa induction chemotherapy for locally advanced head and neck cancer

From: Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

Squamous cell carcinoma – no. (%)

102 (90)

Primary disease site – no. (%)

 Oral cavity

7 (6)

 Oropharynx

26 (23)

 Nasosinus

11 (10)

 Nasopharynx

10 (9)

 Hypopharynx

27 (24)

 Larynx

31 (27)

 Adenopathy without primitif

1 (1)

Laryngeal preservation – no. (%)

44 (39)

Stage – no. (%)

 II

2 (2)

 III

32 (28)

 IVA

51 (45)

 IVB

28 (25)

Tumor size – no. (%)

 T1

3 (3)

 T2

15 (13)

 T3

52 (46)

 T4

42 (37)

 Tx

1 (1)

Nodal status – no. (%)

 N0

26 (23)

 N1

13 (11)

 N2

53 (47)

 N3

21 (19)

  1. aTPF docetaxel, cisplatin, 5-fluorouracil